Fortem Financial Group »

Corvus Pharmaceuticals shares owned by Fortem Financial Group

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Fortem Financial Group from 13F filings

Historical chart of Fortem Financial Group investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Fortem Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Fortem Financial Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $20k 11k 1.78

More positions owned by Fortem Financial Group

Alps Etf Tr Alerian Mlp (AMLP)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Global X Fds Global X Uranium (URA)
NVIDIA Corporation (NVDA)
Spdr Ser Tr S&p Metals Mng (XME)
Select Sector Spdr Tr Sbi Materials (XLB)
Microsoft Corporation (MSFT)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Kla Corp Com New (KLAC)
Broadcom (AVGO)
Apple (AAPL)
Dell Technologies CL C (DELL)
Tesla Motors (TSLA)
Simon Property (SPG)

View all positions for Fortem Financial Group

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
Samlyn Capital
Vanguard Group
BlackRock
TowerView
Geode Capital Management
BVF
Morgan Stanley
Bridgeway Capital Management
Two Sigma Advisers
Susquehanna International
Two Sigma Investments
Connor, Clark & Lunn Investment Management
Northern Trust
Jackson Square Capital

View all funds holding Corvus Pharmaceuticals